NTEK will take off and leave people in the dust as soon as

New Post Public Reply Private Reply Replies (2) Message Board
Atlas1 Dean405 #23110
NTEK will take off and leave people in the dust as soon as they make a major announcement that includes NO further dilution necessary. Until such time as they do that I don't expect to see any sustainable rise in pps. They still have a little more than 50% left of the AS. I hope they don't convert all of it but given their past, I have to assume there's a good chance they will. So to any sideliner's out there, you still have time to buy at these ultra depressed prices but not for much longer.

Atlas1
NTEK...GET SUMMM!!!

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 1

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 2

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 2

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 3

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 3

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 1

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 2

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 2

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading

Top 5 Most Recently Viewed Articles

Spirit Airlines Seeks Revival with Frontier Merger Talks

Updated Category News Views 102

Spirit Airlines Stock Steers Towards Merger Opportunities Spirit Airlines, Inc. (NYSE: SAVE) shares are witnessing a significant uptick as discussions surrounding a merger with Frontier Group Holdings Inc (NASDAQ: ULCC) have resurfaced. Understanding the Current Landscape Amidst challenges with bondholders and looming financial difficulties, Frontier has reignited its...

Continue Reading
CLEAR Secure, Inc. Declares Quarterly Dividend Payment

Updated Category News Views 121

CLEAR Secure, Inc. Declares Quarterly Cash Dividend NEW YORK – Clear Secure, Inc. (NYSE: YOU) has made a significant announcement regarding its quarterly dividend. The company’s Board of Directors declared a regular quarterly dividend of $0.125 per share. This dividend is set to be payable on June 17 to holders of record of Class A and Class B Common Stock as of the...

Continue Reading
Facility Management Market Growth Insights for the Near Future

Updated Category News Views 139

Overview of the Facility Management Market The Facility Management Market is on an impressive trajectory, expected to grow significantly in the coming years. Projections indicate that the market value will rise to USD 138.50 billion by 2030, up from USD 61.08 billion in 2025. This growth represents a compound annual growth rate (CAGR) of 17.8% between 2025 and 2030,...

Continue Reading
FDA's Recent Changes to Enhance Gene Therapy Accessibility

Updated Category News Views 170

FDA Approves Changes for Gene Therapies The U.S. Food and Drug Administration (FDA) has recently announced significant updates regarding gene therapies approved for treating blood cancers. This decision, aimed at improving patient access to potentially life-saving treatments, involves the elimination of the Risk Evaluation and Mitigation Strategies (REMS) for certain...

Continue Reading
Simplilearn Welcomes Shane Clem as New Vice President of Strategic Partnerships

Updated Category News Views 198

Simplilearn's New Appointment Enhances Strategic Growth Simplilearn, recognized as a leader in digital upskilling, is thrilled to announce Shane Clem's appointment as Vice President of Strategic Partnerships. Bringing over two decades of experience, Shane is set to make significant contributions by bolstering relationships with universities, institutions, and industry...

Continue Reading